Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
Healthcare & Pharma
Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
Visiongain Publishes Human Microbiome Market Report 2023-2033
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.
Visiongain Publishes Allergic Rhinitis Drugs Market Report 2023-2033
The global Allergic Rhinitis Drugs market was valued at US$12,025.2 million in 2022 and is projected to grow at a CAGR of 3.78% during the forecast period 2023-2033.
Visiongain Publishes Women’s Health Market Report 2023-2033
The global Women’s Health market was valued at US$36,567.3 million in 2022 and is projected to grow at a CAGR of 4.1% during the forecast period 2023-2033.
Visiongain Publishes Biodefence Market Report 2023-2033
The global Biodefence market was valued at US$14,675.0 million in 2022 and is projected to grow at a CAGR of 7.78% during the forecast period 2023-2033.
Visiongain Publishes Neurotech Devices Market Report 2023-2033
The global Neurotech Devices market was valued at US$11,582.1 million in 2022 and is projected to grow at a CAGR of 13.78% during the forecast period 2023-2033.
Visiongain Publishes Wearable Brain Devices Market Report 2023-2033
The global Wearable Brain Devices market was valued at US$276.0 million in 2022 and is projected to grow at a CAGR of 11.4% during the forecast period 2023-2033.
Visiongain Publishes Asthma & COPD Therapies Market Report 2023-2033
The global Asthma & COPD Therapies market is estimated to be valued at US$47.85 billion in 2023 and is projected to grow at a CAGR of 7.31% during the forecast period 2023-2033.
Visiongain Publishes Point of Care Diagnostics Market Report 2023-2033
The global Point of Care Diagnostics market is estimated to be valued at US$43.05 billion in 2023 and is projected to grow at a CAGR of 8.8% during the forecast period 2023-2033.
Visiongain Publishes Infectious Disease Diagnostics Market Report 2022-2032
The global Infectious Disease Diagnostics market was valued at US$ 28,272.2 million in 2021 and is projected to grow at a CAGR of 6.61% during the forecast period 2022-2032.
Visiongain Publishes Monoclonal Antibody Discovery and Analysis Market Report 2022-2032
The global Monoclonal Antibody Discovery and Analysis market was valued at US$5,234 million in 2021 and is projected to grow at a CAGR of 9.0% during the forecast period 2022-2032.
Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2022-2032
The global CMO of Sterile Injectable Drugs market was valued at US$19,090.4 million in 2021 and is projected to grow at a CAGR of 9.10% during the forecast period 2022-2032.
Neurostimulation Devices Market Report 2023-2033
The global Neurostimulation Devices market is valued at US$8,127.3 million in 2022 and is projected to grow at a CAGR of 11.35% during the forecast period 2023-2033.
Visiongain Publishes Cardiovascular Devices Market Report 2023-2033
The global Cardiovascular Devices market is estimated to be valued at US$59.57 billion in 2022 and is projected to grow at a CAGR of 6.92% during the forecast period 2023-2033.
Visiongain Publishes Respiratory Inhalers Market Report 2023-2033
The respiratory inhalers market is valued at US$42.93 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
Visiongain Publishes Protein Expression, Purification and Isolation Technology Market Report 2022-2032
The Global Protein Expression, Purification and Isolation Technology market was valued at US$9,305.7 million in 2021 and is projected to grow at a CAGR of 9.79% during the forecast period 2022-2032.
Visiongain Publishes Alzheimer’s Therapeutics Market Report 2022-2032
The Alzheimer’s Therapeutics market is valued at US$2,870.25 million in 2022 and is projected to grow at a CAGR of 9.17% during the forecast period 2022-2032.
Visiongain Publishes Gene Amplification Technologies Market Report 2023-2033
The Gene Amplification Technologies market was valued at US$4,587 million in 2022 and is projected to grow at a CAGR of 9.8% during the forecast period 2023-2033.
Visiongain Publishes Stem Cell Technologies and Applications Market Report 2022-2032
The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.
